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Dental implant supported restorations have been added substantially to the clinical treatment options presented to patients.
However, complications with these treatment options also arise due to improper patient selection and inadequate treatment
planning combined with poor follow-up care. The complications related to the presence of inflammation include perimucositis,
peri-implant bone loss, and peri-implantitis. Prevalence rates of these complications have been reported to be as high as 56%.
Treatment options that have been reported include nonsurgical therapy, the use of locally delivered and systemically delivered
antibiotics, and surgical protocols aimed at regenerating the lost bone and soft tissue around the implants. The aim of this article is
to report on three cases and review some of the treatment options used in their management.
1. Introduction
Implant supported restorative treatment has led to increased
treatment options for patients who are either partially or
completely edentulous. However, it has become evident
that while this treatment is successful in many patients,
implant supported restorations are not free of postplacement
complications. Peri-implantitis is defined as an inflammatory
process affecting the supporting hard and soft tissue around
an implant in function, leading to loss of supporting bone.
Peri-implant mucositis is defined as reversible inflammatory
changes of the peri-implant soft tissues without any bone
loss [1, 2]. The prevalence of peri-implant mucositis and
peri-implantitis has ranged from 19 to 65% and 1 to 47%,
respectively [2–4]. The most common etiological factors
associated with the development of peri-implantitis are the
presence of bacterial plaque and host response [5]. The
risk factors associated with peri-implant bone loss include
smoking combined with IL-1 genotype polymorphism, a
history of periodontitis, poor compliance with treatment and
oral hygiene practices, presence of systemic diseases affecting
healing, cement left behind following cementation of the
crowns, lack of keratinized gingiva, and previous history of
implant failure [6].
The treatment of peri-implant disease must include
decontamination of previously exposed or infected implant
surfaces. However, current evidence has shown that non-
surgical therapy for peri-implantitis is minimally effective
even with the adjunctive use of locally delivered or systemic
antibiotics [5, 6]. Surgical access is usually required. The
primary objective of surgical intervention is to allow the
surgeon to instrument the implant surface and to perform
debridement and decontamination. Decontamination and
detoxification of the implant surface can be performed
chemically or mechanically. Reported methods include the
use of air-power abrasives, lasers, saline wash, ultrasonic use,
and the use of chlorhexidine and hydrogen peroxide among
others. These are usually combined with flap surgery [4, 7].
Several case report series have shown short- and long-
term stability of soft tissue attachment along with radio-
graphic bone fill following surgical procedures that have also
included the use of bone regenerative procedures with barrier
membranes, bone substitutes, and growth factors, such as
enamel matrix derivative or platelet derived growth factors
[8, 9]. However, there has been no clear definition in the
existing literature on reosseointegration. Simonis et al. [10]
conducted a systematic review seeking evidence of reosseoin-
tegration after treatment of peri-implantitis on contaminated
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Figure 1: Initial presentation of the cantilever bridge in the maxil-
lary anterior region.
Figure 2: Periapical radiograph of the maxillary anterior region.
implant surfaces. The authors concluded that reosseointe-
gration is possible on a previously contaminated implant
surface. These results were found in experimentally induced
peri-implantitis defects following therapy. The amount of
reosseointegration varied considerably within and between
studies. Implant surface characteristics may influence the
degree of reosseointegration. Surface decontamination alone
cannot achieve substantial reosseointegration on a previ-
ously contaminated implant surface. No method predictably
achieved the complete resolution of the peri-implant defect
[11]. Esposito indicated in hisCochrane review that there is no
reliable evidence suggesting the most effective intervention
for treating peri-implantitis [12].
This article discusses two cases of peri-implant bone loss
and one case of peri-implantitis. The differentiation in the
terms is because inCases 1 and 2 bone loss around the implant
had occurred before the implants were restored. In Case 3,
the patient presented with peri-implantitis many years after
the implant was placed. The aim of the three case reports is
to discuss the treatment of peri-implant bone loss and peri-
implantitis to illustrate treatment modalities and to suggest
a treatment protocol for surgical regenerative procedures for
peri-implant bone loss.
Figure 3: Following the sectioning of the cantilever bridge.
Figure 4: Placement of a paralleling pin to check angulation of the
implant.
2. Case Reports
Case 1 (Successful Treatment of Peri-Implant Bone Loss).
A 48-year-old female, with no significant medical history,
presented to the dental office as she was unhappy with
her anterior cantilever bridge in the upper anterior region
(Figures 1 and 2). Her initial appointment was for a con-
sultation and periodontal exam. Her periodontal findings
were normal with only isolated areas of mild gingival inflam-
mation. Following the initial consultation, the patient was
referred to a prosthodontist to section the bridge and to
fabricate a provisional partial denture and a surgical template
for implant placement (Figure 3). The implant was placed
using a standard protocol (Figure 4). The implant used
was a Straumann Roxolid implant 3.3mm in diameter and
10mm in length. The area was sutured and the patient
was given routine postoperative instructions. The patient
was prescribed Amoxicillin 500mg, 21 capsules to take 1
capsule three times a day for 7 days. Pain control included
using Ibuprofen 600mg every 6–8 hours for days 1 and 2
and then as needed after that. Healing appeared to proceed
uneventfully (Figures 5 and 6). However, at second-stage
surgery, which was done at 3 months following implant
placement, vertical bone loss was noted on the mesial and
distal aspects of the implant (Figure 7). It was decided to
treat the site using the following protocol: the use of titanium
curettes to instrument the implant surface and application of
ethylenediaminetetraacetic acid (EDTA) twice for 2 minutes.
The implant surface was then rinsed with normal saline
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Figure 5: Following implant placement and suturing.
Figure 6: Periapical radiograph following implant placement.
Figure 7: Following a healing phase of about 3months, vertical bone
loss around the implant was noted.
Figure 8: Following the treatment of implant site with EDTA,
FDBA, and Emdogain.
Figure 9: PA radiograph 4 months following bone grafting around
the implant.
following each application. The site was grafted with freeze-
dried bone allograft (FDBA) combined with Emdogain (Fig-
ure 8). A similar post-op protocol was followed. Patient
called the next day following surgery and indicated that
she had fallen at home and hit her lip and that the site of
surgery was bleeding. Following another visit, a second dose
of antibiotics, Clindamycin 150mg, 21 caps, 1 capsule three
times a day for 7 days, was prescribed. Healing proceeded
uneventfully. A periapical radiograph was taken at about
4 months (Figure 9). The patient was referred back to the
prosthodontist for the fabrication of a provisional crown
(Figures 10 and 11). Following a period of about 4months, the
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Figure 10: Provisional crown on the implant.
Figure 11: PA radiograph of provisional crown.
patient had her final restoration fabricated (Figures 12 and 13).
She is currently on a 6-month dental prophylaxis schedule.
Case 2 (Successful Treatment of Peri-Implant Bone Loss). A
58-year-old healthy male was referred to the dental clinic
to evaluate tooth #18 (Figure 14) which presented with a
cracked root and significant interradicular radiolucency. The
tooth was deemed to have a “hopeless prognosis.” The plan
was to extract the tooth and perform “socket grafting” to
prepare the site for a future implant supported restoration.
The tooth was sectioned and, following extraction, the socket
was curetted and then graftedwith freeze-dried bone allograft
mixed with calcium sulfate. Calcium sulfate was also used as
a barrier over the bone graft material (Figure 15). The patient
was prescribed Amoxicillin 500mg, 21 capsules to take 1
capsule three times a day for 7 days. Pain control included
using Ibuprofen 600mg every 6–8 hours for days 1 and 2 and
then as needed after that. Following a healing period of four
months, a flapless approach was used to place a 4.8 × 8mm
Straumann Roxolid implant in the site (Figure 16). Healing
appeared to proceed uneventfully. A similar post-op protocol
was followed.However, at second-stage surgery, bone losswas
noted around the implant (Figure 17). Just as in Case 1, it was
decided to treat the site using the following protocol: the use
Figure 12: Final restoration of the implant in the #10 region.
Figure 13: One year following implant restoration.
of titanium curettes to instrument the implant surface and
the application of ethylenediaminetetraacetic acid (EDTA)
twice for 2 minutes. The implant surface was then rinsed
with normal saline following each application. The site was
grafted with freeze-dried bone allograft (FDBA) combined
with Emdogain (Figure 18). A similar post-op protocol to
what had been done previously was followed. A follow-up
radiograph was taken at about 6 months (Figure 19). The
patient was then seen by his general dentist and the final
crown was fabricated. Healing appeared to be progressing
satisfactorily. The crown was fabricated 6 months following
surgery to treat peri-implant bone loss. The patient has been
followed for one year following the restoration of the implant
with satisfactory bone levels being maintained.
Case 3 (Unsuccessful Treatment of Peri-Implantitis). A 50-
year-old patient was referred to the dental office to evaluate
the peri-implantitis around the implant supported restora-
tion in the #30 region (Figure 20). The implant had been
previously placed and restored in a different office in a
different state. The patient was not sure how long ago
treatment had been completed but reported that it had been at
least 5 years since the implant was restored. Patient presented
with deep peri-implant probing depths alongwith presence of
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Figure 14: Tooth #18 presented with a hopeless prognosis.
Figure 15: Following socket grafting—healing at 3 months.
exudate that could be expressedwhen the peri-implant tissues
were palpated. The patient did not want to have the implant
removed at that time. Initial treatment included a nonsurgical
treatment phase that consisted of instrumentation around
the implant with an ultrasonic instrument with an implant
insert along with a titanium curette followed by subgingival
irrigation with chlorhexidine gluconate (0.12%) and the
placement of a locally delivered antimicrobial. Minocycline
(Arestin) was placed in the site to help with the healing
process. However, the site continued to present with evidence
of inflammation. Surgery to access the peri-implant defect
was performed 6 months following nonsurgical treatment.
The surgical treatment consisted of flap elevation, instru-
mentation with hand, and ultrasonic instruments, followed
by the placement of freeze-dried bone allograft along with
platelet-rich plasma. Following early healing, the level of
inflammation had reduced. However about 1 year following
treatment (Figure 21), therewas evidence of increased inflam-
mation along with the presence of some exudate in the site.
Nonsurgical treatment was continued and the patient was
compliant with keeping his appointments and maintaining
his oral hygiene. At each appointment, the patient was
counselled to have the implant removed. The patient was
reluctant to have the implant removed. However, he finally
consented to have the implant removed and the site prepared
for a possible future implant supported restoration (Figures
22 and 23). Patient is scheduled to have the procedure done
in 2017.
Figure 16: Implant was placed at 4months using a flapless approach.
Figure 17: Presence of peri-implant bone loss.
Figure 18: Sixmonths following grafting of the sitewith freeze-dried
bone allograft and a resorbable membrane.
Figure 19: The implant was restored following a healing period of 6
months. The patient has been followed for 1 year now.
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Figure 20: Peri-implant bone loss around the implant in the #30
site.
Figure 21: One year following treatment. Minimal to no improve-
ment following surgical treatment.
3. Discussion
The treatment of peri-implantitis and peri-implant bone loss
presents a significant clinical problem facing many clinicians
and their patients.The search for predictable treatment proto-
cols is ongoing. Based on the two case reports presented and
on the authors experience to date, the use of surface instru-
mentation of the exposed implants with an ultrasonic instru-
ment using a special insert, combined with the application of
EDTA for 2 minutes twice along with the use of Emdogain
and freeze-dried bone allograft, has shown positive results.
The major challenge to effectively treating peri-implan-
titis fundamentally resides in our difficulty of conceptually
tying together three equally important determinants that
define the success or failure of an implant, that is, “implant
survival rate,” “implant success rate,” and “implant compli-
cation rate.” Unfortunately, contemporary clinical implant
reports tend to heavily stress on the “survival rate” and/or the
“success rate” of an implant but very rarely draw attention to
the “complication rate” that comes with defining the failure
of an implant. This has both good and bad unintended
consequences. On the positive side, since both “survival
rate” and “success rate” have been shown to be exceptionally
high, clinicians are inclined to revolve their entire treatment
philosophy around the view that an endosseous implant is the
gold standard when it comes to replacing an individual tooth.
Yet, on the flip side of the coin, the overreliance of making
a treatment decision on the basis of “survival rate” and/or
“success rate” alone can negatively reinforce themisconceived
Figure 22: Four years following treatment. The site continued to
present with inflammation and deep peri-implant probing depths.
Figure 23: Six years following treatment. The patient has finally
consented to having the implant removed and the site regrafted and
evaluated following healing for possible future implant placement.
assumption that dental implants are infallible. In other words,
a dental implant will never fail. This notion is far from the
truth! And, it becomes even more concerning when one con-
siders that, with the growing number of implants being placed
by dentists, there is also a concomitant rise in the number
of implant-related complications. Thus, while both “survival
rate” and “success rate” are important considerations, the
overreliance of building our entire treatment philosophy
on these two overarching factors means that we are putting
too much weight on the success and/or survivability of the
implant, but little on factoring the complications which could
have clinically significant consequences on the long-term
success and failure of the implant. The importance of the
“complication rate” was highlighted in a 10–16-year clinical
study which reported the incidence of implant biological
complications, namely, peri-implantitis, to be approximately
17% [10]. A similar finding was reported in a recent meta-
analysis which revealed a weighted mean prevalence of 22%
for peri-implantitis [3]. To put these numbers in perspective,
the American Academy of Implant Dentistry (AAID) has
reported that approximately 5.5 million implants were placed
in the United States in 2006 alone. Thus, using the numbers
provided above, it can be inferred that over one million
dental implants that were placed ten years ago are at risk
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of peri-implantitis at present day. This is quite a sobering
statistic and, if accurate, is a harbinger of what is to come.
These three case reports are powerful and vivid reminders
of the overwhelming destructive consequences of peri-
implantitis. At the same time, these case reports illustrate
that peri-implantitis—despite being difficult to treat—is still a
treatable condition which demands early treatment and early
intervention. For instance, Cases 1 and 2 clearly demonstrate
that early detection and immediate treatment was critical
in arresting peri-implant breakdown and in achieving an
optimal regenerative outcome. On the other hand, Case 3 is
a prime example of what could possibly happen if surgical
intervention is delayed. Over time, the peri-implant infection
festers and the prognosis of the implant worsens to the point
that any future surgery is for naught. Hence, the common
theme from all three cases is that treatment intervention will
only have its maximum therapeutic benefits if it is detected
early and promptly addressed with appropriate means. Only
then can we see an outcome that reverses the effects of
peri-implantitis, improves the survivability of the implant,
and reduces the risk of complications that could potentially
threaten the health of the implant.
Peri-implantitis is a complex multifactorial disease that
shares many clinical characteristics and risk factors asso-
ciated with periodontitis [13, 14]. As such, conventional
treatment of peri-implantitis follows along the same lines
of surgical treatment of periodontitis. In its most basic
form, therapeutic intervention can be subdivided into two
phases: (1) the anti-infective phase and (2) the regenerative
phase. Similar to treating periodontitis, the primary objective
of the anti-infective phase is mechanical decontamination
of the implant surface while the primary objective of the
regenerative phase is to establish an environment that is
conducive to reosseointegration.
From a theoretical standpoint, the rationale for both the
anti-infective phase and the regenerative phase has a strong
basis. Yet, what remains open to discussion is determining
which anti-infective strategy predictably achieves the best
therapeutic outcome. Currently, there is no consensus as to
which anti-infective strategy is the gold standard. Several
conventional anti-infective modalities have been proposed.
Mechanical scaling with plastic curettes or titanium curettes
and ultrasonic scaling with an implant insert tip are examples
of commonly used anti-infective strategies employed to treat
peri-implantitis. As shown in the three case reports, the
regenerative phase of treatment was preceded by some sort
ofmechanical debridement and/or ultrasonic debridement of
the implant surface.Thebenefit of employing this type of anti-
infective strategy is that it is gentler to the implant surface
(less risk of damage to the surface). The limitation, however,
is that even with thorough debridement there is no guarantee
that the operator can entirely remove the plaque biofilm that
has contaminated the implant surface. Furthermore, anti-
infective therapy, when done thoroughly and meticulously,
can be time-consuming and lead to both patient and operator
fatigue. Another recently proposed anti-infective strategy is
the use of titanium brushes (Straumann TiBrush). The
titanium brush has a standard dental coupling that fits
onto a surgical hand piece while the other side has thin
titanium bristles. When activated, the titanium bristles brush
the implant surface in a clockwise and counterclockwise
manner, thereby sweeping the plaque biofilm away from
the implant. The titanium brush appears to be a more
efficient means of removing the plaque biofilm when used
in conjunction with manual implant scalers. In fact, in a
recent preclinical study investigating the in vivo effects of
the titanium brush on ligature-induced experimental peri-
implantitis, it was found that the titanium brush resulted
in a statistically significant reduction in inflammation and
statistically significant improvement in bony defect fill [15].
While this may be a promising anti-infective strategy, addi-
tional studies are required to further support the use of
titaniumbrushes. Other types of anti-infective strategies have
been proposed, such as using an air-powder abrasive system
with sodium bicarbonate and newer treatment modalities,
such as laser therapy and photodynamic therapy. These anti-
infective strategies may hold the key to providing results
that are superior to conventional therapy. However, like
conventional anti-infective strategies, they require further
analyses to clarify their impact on halting the devastating
consequences of peri-implantitis.
Similar to anti-infective therapy, there is a lack of a gold
standard regenerative approach. Current peri-implant regen-
erative strategies follow along the same path as guided tissue
regeneration [7, 10]. Yet, what makes peri-implant regenera-
tive therapy a challenge is the multiple factors that can influ-
ence the success or failure of the outcome, namely, surface
topography, severity of the peri-implantitis inflammatory
lesion, and the therapeutic effectiveness of the type of anti-
infective therapy implemented. Ongoing research is being
conducted to determine which regenerative protocol offers
the best chance in terms of facilitating reosseointegration.
But even then, the predictability of a regenerative outcome
is predicated on the effectiveness of anti-infective therapy.
In all three case reports, the clinician performed exhaustive
and thorough surgical debridement of the implant surface.
Yet, in spite of the thoroughness of implant debridement,
only 2 of the three cases resulted in a successful regenerative
outcome. The most plausible explanation would be that anti-
infective therapy in Case 3 was inadequate in eliminating
the pathogenic plaque biofilm from the roughened implant
surfaces. This would suggest that successful treatment of
peri-implantitis depends more on the quality of surgical
debridement, rather than the selection of a certain type of
regenerative material and/or the regenerative technique.
4. Conclusions and Practical Implication
Cases 1 and 2 were examples of patients who presented with
evidence of early peri-implant bone loss following implant
placement. These patients responded well to the treatment
procedures that were aimed at restoring the lost bone tissue.
Case 3 was an example of a patient who presented with
long-standing inflammation and bone loss. The difference
between successful treatment and failure may revolve around
the degree of chronicity associated with the bone loss. Early
detection and treatment of mucositis, peri-implant bone loss,
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and peri-implantitis appear to be key factors that determine
the prognosis of implant supported restorations. The authors
conclude that careful patient selection and experienced clin-
icians involved with the surgical and restorative phases of
treatment combined with regular clinical and radiographic
examination around implant supported restorations are the
key to long-term clinical and functional success for implant
supported restorations.
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